Method of determining analyte concentration in a sample using infrared transmission data

• US 7,593,108 B2
• Filed: 08/20/2007
• Issued: 09/22/2009
• Est. Priority Date: 04/15/2003
• Status: Expired due to Fees

• Current Assignee: OptiScan Biomedical Corporation
• Original Assignee: OptiScan Biomedical Corporation
• Inventors: Sterling, Bernhard B., Hartstein, Philip C., Gaffney, Robert D., Braig, James R., Goldberger, Daniel S.
• Primary Examiner(s): Toatley, Jr.; Gregory J
• Assistant Examiner(s): Underwood; Jarreas C
• Application Number:
  US11/841,878
• Publication Number:
  US 20080212071A1
• Time in Patent Office: 764 Days
• Field of Search: 356300-334, 356402-425, 356450-458
• US Class Current: 356/436
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: G01N 21/03 Cuvette constructions
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427
• CPC Class Codes: G01N 21/35 using infrared light G01N21/39 takes precedence

Abstract

A method determines an analyte concentration in a sample. The sample includes the analyte and a substance. The method includes providing absorption data of the sample. The method further includes providing reference absorption data of the substance. The method further includes calculating a substance contribution of the absorption data. The method further includes subtracting the substance contribution from the absorption data, thereby providing corrected absorption data substantially free of a contribution from the substance.

Claims

1. A method of determining an analyte concentration in a sample using infrared spectroscopy, the method comprising:

providing a source of infrared radiation comprising a plurality of wavelengths and a detector responsive to infrared radiation at the plurality of wavelengths;

placing a sample in a sample element having a shape;

irradiating the sample element with infrared radiation from the source after the sample has been placed in the sample element;

detecting with the detector at least a portion of the infrared radiation transmitted through the sample element and the sample;

determining measured absorption data at the plurality of wavelengths, the measured absorption data determined based at least in part on the detected portion of the infrared radiation; and

correcting the measured absorption data to provide corrected absorption data, wherein the corrected absorption data is corrected for a non-analyte contribution that is, at least in part, from the shape of the sample element.

2. The method of claim 1, wherein the sample comprises blood.

3. The method of claim 1, wherein the sample comprises plasma.

4. The method of claim 1, wherein the sample element comprises a cuvette.

5. The method of claim 1, further comprising determining an analyte concentration in the sample based at least in part on the corrected absorption data.

6. The method of claim 5, wherein determining the analyte concentration comprises correcting the corrected absorption data for at least one substance that interferes with determining the analyte concentration.

7. The method of claim 1, wherein correcting the measured absorption data comprises correcting for a pathlength of the sample element.

8. The method of claim 1, wherein correcting the measured absorption data comprises correcting for bowing of the sample element.

9. The method of claim 1, wherein correcting the measured absorption data comprises correcting for at least one of a curvature or a wedge of the sample element.

10. The method of claim 1, where correcting the measured absorption data comprises correcting for a wavelength-dependent non-analyte contribution to the measured absorption data.

11. The method of claim 1, where correcting the measured absorption data comprises correcting for a non-analyte contribution based at least in part on a temperature of the sample.

12. The method of claim 1, further comprising separating a blood sample into plasma and other constituents, and wherein the sample comprises at least a portion of the plasma.

13. The method of claim 1, wherein at least some of the plurality of wavelengths are between 4 microns and 11 microns.

14. The method of claim 1, wherein the sample comprises blood or plasma, and at least some of the plurality of wavelengths are between 4.4 microns and 5.5 microns.

15. The method of claim 1, wherein correcting the measured absorption data comprises calculating a distortion parameter representative of non-parallelism of the sample element.

16. A method of determining an analyte concentration, the method comprising:

storing in a memory absorption data of a sample of body fluid disposed in a sample element having a shape, the absorption data comprising a plurality of wavelengths;

transforming the absorption data into corrected absorption data using a processor configured to have access to the memory, wherein transforming comprises correcting the absorption data for a non-analyte contribution that is, at least in part, from the shape of the sample element; and

calculating, with the processor, an analyte concentration in the sample of body fluid, wherein calculating is based at least in part on the corrected absorption data.

17. The method of claim 16, wherein correcting the absorption data comprises correcting for a pathlength of the sample element.

18. The method of claim 16, wherein the sample element comprises one or more windows, and correcting the absorption data comprises correcting for a deviation from planarity of at least one of the windows.

19. The method of claim 18, wherein correcting for a deviation from planarity comprises correcting for a window having a portion that is curved or bent.

20. The method of claim 16, wherein the sample element comprises two opposed windows, and correcting the absorption data comprises correcting for a deviation of the two opposed windows from a parallel orientation with respect to each other.

21. The method of claim 16, wherein transforming the absorption data further comprises correcting for the temperature of the sample of body fluid.

22. The method of claim 16, further comprising communicating information related to the analyte concentration to a display.